Study of A-101 for the Treatment of Seborrheic Keratosis

Clinical trial NCT02260180 · COMPLETED

Trial details

NCT number: NCT02260180
Sponsor: Aclaris Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Seborrheic Keratosis

Start date: 2014-10-01
Primary completion: 2015-03-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.